Welcome to our dedicated page for Cognex SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cognex Corporation (CGNX) SEC filings page on Stock Titan aggregates the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, providing a structured view of how this industrial machine vision issuer reports its financial and corporate information. Cognex is incorporated in Massachusetts and files under Commission File Number 001-34218, with its common stock listed on NASDAQ under the symbol CGNX.
Among the key documents available are Form 10-K annual reports and Form 10-Q quarterly reports, where Cognex discusses its machine vision business, risk factors, and financial statements. These filings are important for understanding trends in logistics and factory automation demand, as well as the company’s investment in AI-enabled vision products, as referenced in its public communications.
Investors will also find Form 8-K current reports that Cognex uses to announce material events. Recent 8-K filings include the release of quarterly financial results, dividend declarations, and an audit firm rotation in which the Audit Committee selected KPMG LLP as the independent registered public accounting firm for a future fiscal year, following Grant Thornton LLP. Such filings provide timely insight into corporate actions and governance decisions.
On this page, users can monitor real-time updates from EDGAR, including 8-Ks, 10-Qs, 10-Ks, and other forms that Cognex may file. Stock Titan’s tools offer AI-powered summaries that help explain the contents of lengthy filings, highlight key sections, and clarify technical language around accounting, risk disclosures, and strategic priorities. In addition, Form 4 insider transaction reports, when filed, can be accessed to review share transactions by Cognex officers, directors, or significant shareholders.
By using the CGNX filings page, investors and researchers can quickly move from raw SEC documents to clearer explanations of how Cognex presents its financial condition, machine vision strategy, and corporate developments in official filings.
Cognex Corporation director Marjorie Sennett reported the exercise and conversion of 2,913 restricted stock units into an equal number of Cognex common shares at a price of $0.00 per share. After this transaction, she directly holds 25,936 common shares and 4,817 restricted stock units.
The restricted stock units each represent a contingent right to receive one share of common stock and vest in stages of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.
COGNEX CORP director Sachin Lawande exercised restricted stock units into common shares. On February 21, 2026, he converted 2,913 restricted stock units into 2,913 shares of Cognex common stock at $0.00 per share through a derivative exercise.
After this transaction, he directly held 28,431 shares of common stock and 4,817 restricted stock units. Each restricted stock unit represents a right to receive one share of Cognex common stock, and these units vest 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.
Cognex director Anthony Sun reported an equity award transaction involving restricted stock units (RSUs) and common shares. On February 21, 2026, he exercised 2,913 RSUs, converting them at $0.00 per unit into 2,913 shares of Cognex common stock held directly. Following this conversion, his directly held common stock position reported in this filing is 335,085 shares, while the exercised RSU grant balance is now 0 units.
The filing also lists additional indirect holdings through Sun Management Associates, LLC, including several non-qualified stock options with reported remaining amounts ranging from 13,000 to 26,000 shares and 52,608 shares of common stock. A footnote states that Sun is a member of this LLC and disclaims beneficial ownership of those securities except to the extent of his pecuniary interest. Another footnote explains that each RSU represents a contingent right to receive one share of Cognex common stock and that the applicable RSU award vests 20%, 30%, and 50% on the first, second, and third anniversaries of its February 21, 2023 grant date.
Cognex Corporation CEO & President Matthew Moschner reported equity compensation activity involving restricted stock units and related tax withholding. On February 20 and 21, 2026, restricted stock units covering 3,042 and 3,495 shares were exercised into an equal number of Cognex common shares at $0.00 per share.
To satisfy tax withholding obligations on these vesting awards, 893 and 1,026 common shares were automatically withheld at a price of $56.03 per share, as described in the footnotes. After these transactions, Moschner held 16,465 shares of Cognex common stock directly, along with multiple outstanding non-qualified stock options and additional restricted stock units.
COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales. On February 20–21, 2026, he exercised multiple non-qualified stock options and restricted stock units, receiving Cognex common stock through derivative exercises at stated exercise prices such as $33.04, $38.39, and $39.44 per share.
He then sold a total of 61,900 shares of common stock in open-market transactions at prices around $55.98–$56.24, and some additional shares were disposed of to satisfy tax withholding obligations on vested restricted stock units, as described in the footnotes. After these transactions, Kuechen directly owned 6,032 shares of Cognex common stock.
Cognex EVP Carl Gerst reported a series of stock transactions involving Cognex common shares and restricted stock units. On February 20, 2026, he exercised restricted stock units into 6,846 common shares and another 6,846 common shares, then had 2,010 shares withheld to cover tax obligations and sold 3,804 shares in open‑market trades at about $55.99 per share. On February 21, 2026, additional restricted stock units converted into 8,791 common shares, with 3,095 shares withheld for taxes. On February 23, 2026, he sold 10,532 common shares in open‑market transactions at an average price of about $55.93 per share under a Rule 10b5‑1 trading plan. After these trades, his reported direct common‑stock holdings were 0 shares, while the filing notes outstanding restricted stock units that vest 20%, 30%, and 50% on the first, second, and third anniversaries of the 2023 and 2024 grant dates.
Cognex Corporation vice president and principal accounting officer Laura Ann Macdonald reported routine equity compensation activity. On February 20, 2026 and February 21, 2026, restricted stock units converted into 1,902 and 2,754 shares of common stock, respectively, through derivative exercises at a stated price of $0.00 per share.
To satisfy tax withholding obligations on these vestings, 559 and 809 common shares were automatically withheld at $56.03 per share, as described in the footnotes. Following these transactions, Macdonald directly held 7,211 Cognex common shares, along with multiple non-qualified stock option and restricted stock unit positions. An additional 20 common shares are held indirectly by her child, with beneficial ownership disclaimed except for any pecuniary interest.
Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported the vesting of restricted stock units and related tax withholding transactions. On February 20, 2026 and February 21, 2026, she acquired a total of 9,098 shares of common stock through exercises of restricted stock units, each unit converting into one share.
To cover tax withholding obligations on these vested awards, 1,117 shares on February 20, 2026 and 1,555 shares on February 21, 2026 were disposed of at $56.03 per share, as share-withholding rather than open-market sales. After these transactions, she directly owned 15,013 shares of Cognex common stock.
Cognex insider filing reports an intended sale of 10,532 shares of common stock under Rule 144. The filing lists aggregate value $590,107.96 and states shares outstanding were 165,707,920 as of 02/23/2026.
The excerpt also reports prior 10b5-1 sales by Carl W. Gerst III on 02/20/2026 of 3,804 shares for $212,979.49. Timing and method for the 10,532-share disposition are set out in the notice.